Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023

BUY
$133.98 - $160.47 $3.29 Million - $3.94 Million
24,583 New
24,583 $3.6 Million
Q3 2019

Nov 13, 2019

SELL
$125.18 - $143.24 $10,014 - $11,459
-80 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$125.55 - $144.48 $2,636 - $3,034
21 Added 35.59%
80 $11,000
Q1 2019

May 13, 2019

SELL
$121.81 - $142.95 $243 - $285
-2 Reduced 3.28%
59 $8,000
Q4 2018

Feb 08, 2019

SELL
$115.94 - $166.74 $17,159 - $24,677
-148 Reduced 70.81%
61 $8,000
Q3 2018

Nov 13, 2018

BUY
$161.01 - $180.57 $483 - $541
3 Added 1.46%
209 $35,000
Q2 2018

Aug 10, 2018

BUY
$146.33 - $183.18 $10,682 - $13,372
73 Added 54.89%
206 $35,000
Q4 2017

Feb 09, 2018

BUY
$131.06 - $150.39 $5,766 - $6,617
44 Added 49.44%
133 $18,000
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $12,693 - $13,848
89
89 $13,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.81B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.